Logotype for Novakand Pharma AB

Novakand Pharma (NOVKAN) investor relations material

Novakand Pharma Q3 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Novakand Pharma AB
Q3 2025 earnings summary21 Nov, 2025

Executive summary

  • Letter of intent with Recardio Inc. was terminated due to inability to secure financing for a joint specialty pharma company.

  • Company name changed from Kancera AB to Novakand Pharma AB following AGM decision.

  • Board initiated a reverse takeover process after strategic review found capital raising for continued operations unfeasible.

  • CEO Peter Selin resigned; will assist through March 2026 if needed.

  • SEK 18 million write-down of intangible assets related to the fractalkine program.

Financial highlights

  • Net sales were SEK 0 million for both Q3 and the nine-month period (same as prior year).

  • Q3 R&D expenses: SEK 4.0 million (down from SEK 10.2 million year-over-year); nine-month R&D: SEK 19.8 million (down from SEK 31.5 million).

  • Q3 operating loss before impairment: SEK -5.1 million (improved from SEK -11.5 million); after impairment: SEK -23.1 million.

  • Loss after financial items for Q3: SEK -23.1 million (vs. SEK -11.1 million); nine-month loss: SEK -42.3 million (vs. SEK -34.9 million).

  • Cash flow from operating activities Q3: SEK -5.3 million (vs. SEK -17.8 million); cash and cash equivalents at period end: SEK 22.3 million (vs. SEK 57.9 million).

Outlook and guidance

  • Board aims to complete a reverse takeover by Q1 2026; if unsuccessful, may recommend de-listing and liquidation.

  • Cash is expected to finance operations for approximately 24 months, with further cost reductions planned.

  • Ongoing search for partners to divest the fractalkine program, though likelihood is assessed as low.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Novakand Pharma earnings date

Logotype for Novakand Pharma AB
Q4 202520 Feb, 2026
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Novakand Pharma earnings date

Logotype for Novakand Pharma AB
Q4 202520 Feb, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Kancera AB is a Swedish biotechnology company focusing on developing pharmaceuticals for the treatment of severe diseases, particularly cancer and inflammatory conditions. The company's efforts are primarily directed towards creating small molecule drug candidates that target disease-promoting immune and cancer cells, specifically utilizing the fractalkine axis. Kancera's work is divided into two main areas: Pharmaceutical Development and Industrial Research and Development (R&D). Solna, Stockholm, Sweden, and its shares are listed on the Stockholm Stock Exchange.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage